Efgartigimod Alfa

Perioperative Efgartigimod for Thymoma and Myasthenia Gravis

Efgartigimod for the Treatment of Acute Optic Neuritis

A multicentre, randomized, double-blind, placebo-controlled phase II/III trial investigating the efficacy of anti-FcRn targeting with efgartigimod as a first-line add-on therapy to IVMP in moderate-to-severe attacks of demyelinating diseases of the central nervous system

Efgartigimod in Anti-NMDA Receptor Encephalitis.

Efficacy and Safety of Nipocalimab vs Efgartigimod in a Randomized, Open-label, Phase 3b, Interventional Trial Including Within Class Switching From Efgartigimod to Nipocalimab